Orpharma is an Australian pharmaceutical company specialising in the supply of niche products including orphan, paediatric and emerging therapeutics. In addition, the company will be supplying devices for a range of applications. The company was founded to serve unmet medical needs and to provide niche solutions. Orpharma is collaborating with global leaders in biotechnology and pharmaceuticals to deliver therapies to patients in need. Giving a ray of hope. Orpharma’s current product portfolio includes innovative medicines targeting rare metabolic diseases, cancer and anti-infectives. Globally we are working on increasing our presence in Asia Pacific, the MENA region and Eastern Europe through partnerships with world leaders in pharmaceutical manufacturing and distribution.